Risk factors for severe COVID-19 and the ISARIC 4C Mortality Score, evidence from the ISARIC Coronavirus Clinical Characterisation Consortium

M. Semple (Liverpool, United Kingdom)

Source: Virtual Congress 2020 – Epidemiology
Session: Epidemiology
Session type: COVID-19
Number: 3614

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Semple (Liverpool, United Kingdom). Risk factors for severe COVID-19 and the ISARIC 4C Mortality Score, evidence from the ISARIC Coronavirus Clinical Characterisation Consortium. Virtual Congress 2020 – Epidemiology

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COvid-19 Interstitial Lung Syndrome (PCOILS)
Source: Virtual Congress 2021 – Imaging
Year: 2021



Risk Score for Subclinical COPD: The NHLBI Pooled Cohorts Study
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021


Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale
Source: ERJ Open Res, 7 (3) 00201-2021; 10.1183/23120541.00201-2021
Year: 2021



Longitudinal characteristics of the Severe Asthma Research Program (SARP) clinical clusters
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020




Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study.
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020




Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020


Prevalence and Risk Factors of Asthma and Allergy-Related Diseases among Adolescents (PERFORMANCE) study: rationale and methods
Source: ERJ Open Res, 4 (2) 00034-2018; 10.1183/23120541.00034-2018
Year: 2018



Risk factors associated with severe COVID-19 in asthma. A report from the Swedish National Airway Register
Source: Virtual Congress 2021 – New evidence from longitudinal asthma cohorts and other key studies
Year: 2021



LATE-BREAKING ABSTRACT: IFN-gamma CA microsatellite Polymorphism is associated with the Susceptibility and Severity to Respiratory Syncytial Virus Infection
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014

Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



Early Fever Associated with Clinical Outcomes in Patients with Coronavirus Disease 2019
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration
Source: Eur Respir J, 53 (3) 1900217; 10.1183/13993003.00217-2019
Year: 2019



Assessment of asthma morbidity by US patients, specialists, Asthma Control Test™, and Asthma Impairment and Risk Questionnaire™
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020


Risk Factors for Mortality of COVID-19 Confirmed Cases Admitted at Lung Center of the Philippines
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021


COPD as a Risk Factor in Primary Care: A Canadian Retrospective Cohort Study
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update
Source: Eur Respir J 2003; 22: 1
Year: 2003


Main and additional predictors of COPD progression
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


High prevalence of rare variants in the Italian National Registry for Severe Alpha1-Antritrypsin Deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 487s
Year: 2003

Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019